ABOS Acumen Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ABOS

Price (delayed)

$0.2397

Market cap

$17.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.54

Enterprise value

-$9.7M

?
Relative Growth: Rel. Growth: 12
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 7
Highlights
Acumen Pharmaceuticals's EPS has increased by 31% YoY and by 6% from the previous quarter
Acumen Pharmaceuticals's net income has increased by 22% YoY
The company's quick ratio has shrunk by 70% YoY and by 26% QoQ
The company's equity has shrunk by 63% YoY and by 40% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.acumenpharm.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ABOS

ABOS stock price

How has the Acumen Pharmaceuticals stock price performed over time
Intraday
14.09%
1 week
-89.44%
1 month
-88.25%
1 year
-89.15%
YTD
-88.64%
QTD
-89.2%

Financial performance

How have Acumen Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$104.72M
Net income
-$103.96M
Gross margin
N/A
Net margin
N/A
Acumen Pharmaceuticals's operating income has increased by 24% YoY
Acumen Pharmaceuticals's net income has increased by 22% YoY

Price vs fundamentals

How does ABOS's price correlate with its fundamentals

Growth

What is Acumen Pharmaceuticals's growth rate over time

Valuation

What is Acumen Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.5
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Acumen Pharmaceuticals's EPS has increased by 31% YoY and by 6% from the previous quarter
The P/B is 83% less than the last 4 quarters average of 2.9 and 62% less than the 5-year quarterly average of 1.3
The company's equity has shrunk by 63% YoY and by 40% QoQ

Efficiency

How efficient is Acumen Pharmaceuticals business performance
ABOS's ROIC has plunged by 135% YoY and by 42% from the previous quarter
ABOS's return on equity has dropped by 71% year-on-year and by 22% since the previous quarter
ABOS's ROA is down by 29% year-on-year and by 11% since the previous quarter

Dividends

What is ABOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABOS.

Financial health

How did Acumen Pharmaceuticals financials performed over time
Acumen Pharmaceuticals's total assets is 68% more than its total liabilities
The company's quick ratio has shrunk by 70% YoY and by 26% QoQ
ABOS's current ratio has dropped by 69% year-on-year and by 23% since the previous quarter
The company's debt is 24% lower than its equity
The debt to equity has soared by 130% YoY and by 38% from the previous quarter
The company's equity has shrunk by 63% YoY and by 40% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.